AI Drug Startup Insilico Weighs Hong Kong IPO After Funding
(Bloomberg) -- Insilico Medicine Inc. is considering an initial public offering after securing funding at a valuation of more than $1 billion, reflecting growing interest in the potential use of AI to discover ground-breaking new drugs. Most Read from …